07:10 PM EST, 11/13/2024 (MT Newswires) -- Fady Ibraham Malik, EVP Research & Development, on November 12, 2024, sold 6,342 shares in Cytokinetics ( CYTK ) for $370,880. Following the Form 4 filing with the SEC, Malik has control over a total of 113,878 shares of the company, with 113,878 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000112760224027240/xslF345X05/form4.xml